CIK 0001501989 · Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273521219
- Phone
- 650.515.3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-17 | Landau Jeffrey B Chief Business Officer | Option exercise | +11,250 | 90,699 | ||
| 2023-12-17 | Landau Jeffrey B Chief Business Officer | Option exercise · Performance Stock Units (PSUs) | −11,250 | 11,250 | ||
| 2023-12-17 | ROWLAND LLOYD A General Counsel | Option exercise | +11,250 | 102,073 | ||
| 2023-12-17 | ROWLAND LLOYD A General Counsel | Option exercise · Performance Stock Units (PSUs) | −11,250 | 11,250 | ||
| 2023-12-17 | BELVIN MARCIA SVP, Chief Scientific Officer | Option exercise | +11,250 | 159,201 | ||
| 2023-12-17 | BELVIN MARCIA SVP, Chief Scientific Officer | Option exercise · Performance Stock Units (PSUs) | −11,250 | 11,250 | ||
| 2023-09-22 | BELVIN MARCIA SVP, Chief Scientific Officer | Sale | −4,119 | $1.30 | $5K | 147,951 |
| 2023-09-22 | Landau Jeffrey B Chief Business Officer | Sale | −4,119 | $1.30 | $5K | 76,379 |
| 2023-09-22 | McCarthy Sean A. CEO | Sale | −14,601 | $1.30 | $19K | 430,755 |
| 2023-09-22 | ROWLAND LLOYD A General Counsel | Sale | −5,486 | $1.30 | $7K | 80,609 |
| 2023-09-20 | BELVIN MARCIA SVP, Chief Scientific Officer | Grant or award | +11,250 | 152,070 | ||
| 2023-09-20 | Landau Jeffrey B Chief Business Officer | Grant or award | +11,250 | 80,498 | ||
| 2023-09-20 | McCarthy Sean A. CEO | Grant or award | +40,000 | 445,356 | ||
| 2023-09-20 | ROWLAND LLOYD A General Counsel | Grant or award | +15,000 | 86,095 | ||
| 2023-07-19 | Chu Yu-Waye Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2023-06-14 | Meyers James R Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-14 | Mohindru Mani Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-14 | Young Matthew P. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-14 | Ashworth Alan Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-14 | Gilbert Halley E Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 8 of 33 · 649 trades